General - Press Releases

Date	Title	Company
04-Jan-2022	Sensorion appoints Aniz Girach as Independent Board Member	Businesswire
04-Jan-2022	Advicenne Announces Commercialization Agreement with FrostPharma AB for Sibnayal™ in the Nordic Region	Businesswire
04-Jan-2022	Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Natera, Inc. (NTRA) on Behalf of Investors	Businesswire
03-Jan-2022	Eagle Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference	Businesswire
03-Jan-2022	ANI Pharmaceuticals to Present at the H.C. Wainwright Bioconnect Virtual Conference	Businesswire
03-Jan-2022	TYME Technologies, Inc. to Present at H.C. Wainwright Bioconnect Virtual Conference	Businesswire
03-Jan-2022	Renovacor to Participate in a Panel Presentation at the 11th Annual LifeSci Partners Corporate Access Event	Businesswire
03-Jan-2022	AngioDynamics to Present at the Needham Virtual Growth Conference	Businesswire
03-Jan-2022	MEI Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	Businesswire
03-Jan-2022	INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Berkeley Lights, Inc. (BLI) Investors and Encourages Investors to Contact the Firm Before February 7, 2022	Businesswire
03-Jan-2022	Onxeo Appoints Julien Miara as New Interim CEO	Businesswire
03-Jan-2022	MaaT Pharma to Present at H.C. Wainwright BioConnect 2022 Virtual Conference	Businesswire
03-Jan-2022	CORRECTING and REPLACING(1): NOXXON Secures €17 Million Expansion of Equity-linked Facility With Atlas to Advance NOX-A12 in Glioblastoma and Pancreatic Cancer Programs	Businesswire
03-Jan-2022	Pryor Cashman Elects Six New Partners and Promotes Eleven to Counsel	Businesswire
03-Jan-2022	The PhagECOLI Project Undertaken by Pherecydes Pharma and the CEA Receives a €2 Million Grant From Bpifrance	Businesswire
03-Jan-2022	FDA Grants ILiAD Biotechnologies Fast Track Designation for Next Generation Pertussis Vaccine BPZE1	Businesswire
03-Jan-2022	Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 12 Years of Age and Older	Businesswire
03-Jan-2022	Vivacitas Oncology Welcomes Dr. Jai Grewal, MD, and Expands Its Neuro-Oncology Advisory Board	Newswire
03-Jan-2022	Transcat Expands Service Business and Geographic Reach with Acquisition of Tangent Labs	Businesswire
03-Jan-2022	CytRx Announces the Appointment of Dr. Stephen Snowdy as Chief Executive Officer	Businesswire